HL
IBB icon

HeadInvest LLC’s iShares Biotechnology ETF IBB Stock Holding History

HeadInvest LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Sell
4,156
-20
-0.5% -$3.44K 0.15% 126
2026
Q1 		$705K Hold
4,176
– – 0.14% 119
2025
Q4 		$705K Hold
4,176
– – 0.14% 120
2025
Q3 		$603K Hold
4,176
– – 0.12% 130
2025
Q2 		$528K Sell
4,176
-10
-0.2% -$1.23K 0.11% 136
2025
Q1 		$535K Sell
4,186
-97
-2% -$13.2K 0.1% 141
2024
Q4 		$566K Sell
4,283
-100
-2% -$14.1K 0.11% 141
2024
Q3 		$638K Sell
4,383
-225
-5% -$32.6K 0.12% 130
2024
Q2 		$632K Sell
4,608
-195
-4% -$26K 0.12% 123
2024
Q1 		$659K Sell
4,803
-887
-16% -$121K 0.13% 118
2023
Q4 		$773K Buy
5,690
+25
+0.4% +$3.05K 0.16% 103
2023
Q3 		$683K Sell
5,665
-320
-5% -$40.7K 0.15% 103
2023
Q2 		$769K Sell
5,985
-840
-12% -$109K 0.17% 96
2023
Q1 		$882K Buy
6,825
+35
+0.5% +$4.58K 0.19% 93
2022
Q4 		$891K Sell
6,790
-217
-3% -$28K 0.2% 89
2022
Q3 		$820K Buy
7,007
+111
+2% +$13.8K 0.2% 88
2022
Q2 		$811K Sell
6,896
-6
-0.1% -$712 0.18% 96
2022
Q1 		$899K Buy
6,902
+243
+4% +$31.7K 0.17% 95
2021
Q4 		$1.02M Buy
6,659
+835
+14% +$129K 0.18% 88
2021
Q3 		$942K Buy
5,824
+62
+1% +$10.4K 0.18% 94
2021
Q2 		$942K Buy
5,762
+32
+0.6% +$4.93K 0.18% 94
2021
Q1 		$862K Buy
5,730
+255
+5% +$40.5K 0.18% 91
2020
Q4 		$829K Hold
5,475
– – 0.18% 90
2020
Q3 		$741K Buy
5,475
+1,042
+24% +$141K 0.21% 83
2020
Q2 		$606K Buy
4,433
+395
+10% +$50.4K 0.19% 91
2020
Q1 		$435K Buy
4,038
+40
+1% +$4.61K 0.16% 100
2019
Q4 		$482K Hold
3,998
– – 0.14% 110
2019
Q3 		$398K Buy
3,998
+600
+18% +$62.8K 0.12% 118
2019
Q2 		$371K Buy
3,398
+210
+7% +$22.3K 0.1% 126
2019
Q1 		$356K Sell
3,188
-3,048
-49% -$334K 0.1% 134
2018
Q4 		$601K Buy
6,236
+3,828
+159% +$406K 0.1% 141
2018
Q3 		$294K Buy
+2,408
New +$284K 0.08% 144

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HeadInvest LLC's IBB Position: Q2 2026 in Review

HeadInvest LLC reduced its iShares Biotechnology ETF (IBB) stake by 0.48% in Q2 2026, selling an estimated $3.44K and leaving 4,156 shares worth $790K. The position accounts for 0.15% of the portfolio, ranked #126.

HeadInvest LLC first reported a position in IBB in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.02M in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • HeadInvest LLC held 4,156 shares of iShares Biotechnology ETF worth $790K as of Q2 2026.
  • HeadInvest LLC sold 20 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.44K.
  • iShares Biotechnology ETF made up 0.15% of HeadInvest LLC's portfolio in Q2 2026, its #126 holding.
  • HeadInvest LLC first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 32 quarters since.
  • HeadInvest LLC's iShares Biotechnology ETF position peaked at $1.02M in Q4 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.